Question 5221
Topic: Biology, Genetics & Bone HealingA 35-year-old female presents with a destructive radiolucent lesion in the distal femur. Core needle biopsy confirms Giant Cell Tumor of bone. Multidisciplinary tumor board recommends neoadjuvant treatment with Denosumab prior to intralesional curettage. Denosumab targets which of the following cellular mechanisms in this specific tumor?
Correct Answer & Explanation
. Inhibition of RANKL produced by the neoplastic mononuclear stromal cells